Modulation of Molecular Fingerprinting in Pediatric Sepsis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorPhoenix Children's Hospital
About this trial
The goal of this study is to demonstrate the sensitivity and specificity of detecting circulating micro RNA (miRNA) biomarkers in pediatric septic patients. It will also follow expression and modulation of levels in response to therapy in comparison to current biomarkers.
Eligibility criteria
Qualifiers
Age 1 through 18 years
Patients admitted to the PICU with concerns for sepsis or those developing sepsis during their admission to the hospital.
Patients must be enrolled int he study from arrival time tot he ED up to 24 hours from the time of initiation of antibiotic therapy for treatment of sepsis or septic shock.
Signed informed consent.
Disqualifiers
Patients <1 year of age and greater than 18 years of age.
Trial design
Treatments tested in this trial
- miRNA in Sepsis
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov